- Report
- August 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- December 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- October 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- September 2025
- 110 Pages
Global
From €3500EUR$4,298USD£3,157GBP
- Report
- October 2025
- 160 Pages
Global
From €3445EUR$3,950USD£3,003GBP
- Report
- October 2025
- 100 Pages
United States
From €5190EUR$5,950USD£4,523GBP
- Report
- August 2025
- 199 Pages
Global
From €3436EUR$3,939USD£2,994GBP
- Report
- September 2025
- 250 Pages
Global
From €3916EUR$4,490USD£3,413GBP
- Report
- February 2026
- 278 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- October 2025
- 250 Pages
Global
From €3916EUR$4,490USD£3,413GBP
- Report
- August 2025
- 136 Pages
Global
From €3488EUR$3,999USD£3,040GBP
- Report
- February 2025
- 135 Pages
Global
From €15696EUR$17,995USD£13,679GBP
- Report
- January 2024
- 150 Pages
Global
From €5190EUR$5,950USD£4,523GBP
- Report
- August 2022
- 120 Pages
Global
From €3925EUR$4,500USD£3,421GBP
- Report
- April 2024
- 115 Pages
Global
From €3925EUR$4,500USD£3,421GBP
- Report
- March 2024
- 200 Pages
Global
From €3620EUR$4,150USD£3,155GBP
- Report
- December 2024
- 30 Pages
Global
From €2399EUR$2,750USD£2,090GBP
- Report
- December 2024
- 30 Pages
Global
From €2399EUR$2,750USD£2,090GBP
- Report
- December 2024
- 30 Pages
Global
From €2399EUR$2,750USD£2,090GBP
- Report
- June 2024
- 200 Pages
Global
From €6934EUR$7,950USD£6,043GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more